Benjamin D. Solomon MD, FACMG

Dr. Solomon has a bachelor’s degree in philosophy from Brown University and a medical degree from Geisel School of Medicine at Dartmouth. He completed medical training in pediatrics and clinical genetics through a joint Children’s National/National Human Genome Research Institute program. After completing this program, Dr. Solomon remained at NHGRI for several years as a Staff Clinician; his work focused on understanding the causes and biology of a number of congenital disorders as well as applying emerging technologies and analytic approaches to genomic and phenotypic datasets in order to ask a variety of clinically-relevant research questions.

Dr. Solomon joined the Inova Translational Medicine Institute (ITMI) in 2013 as the Chief of the Division of Medical Genomics. In this role, Dr. Solomon led a team of clinicians, bioinformaticists, and bench-based scientists to deliver clinical care and conduct genomic research. In 2016, Dr. Solomon became the Managing Director of GeneDx, a genetics/genomics diagnostic company with a strong emphasis on research and the discovery of novel causes of disease. In this role, which he held until returning to NHGRI, he led a team of over 400 molecular geneticists, genetic counselors, and laboratory and research staff. Throughout his entire career, he has always continued to be an avid participant in clinical genomics education, including formal and informal teaching of medical students, residents, fellows, postdoctoral and other trainees, as well as re-educating the existing clinical and scientific workforce about genomics. Additionally, since 2017, Dr. Solomon served as deputy editor-in-chief for the American Journal of Medical Genetics. He has authored and co-authored more than 120 peer-reviewed papers, 10 commentaries, and six book chapters. His research interests involve determining the broad implications of human genomic health, including the development and application of high-throughput and novel related technologies to help predict health outcomes and study the causes and optimal management of both rare and common diseases.